Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 3, p. 254, doi. 10.1038/sj.cgt.7700431
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2002 AND VI 9 AND IP 3
Results: 12
1
2
Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vector.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 3, p. 260, doi. 10.1038/sj.cgt.7700432
- By:
- Publication type:
- Article
3
Gene transfer into human prostate adenocarcinoma cells with an adenoviral vector: Hyperthermia enhances a double suicide gene expression, cytotoxicity and radiotoxicity.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 3, p. 267, doi. 10.1038/sj.cgt.7700433
- By:
- Publication type:
- Article
4
Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells: Role of caspase-8 and mitochondria.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 3, p. 219, doi. 10.1038/sj.cgt.7700434
- By:
- Publication type:
- Article
5
Comparative assessment of TCRBV diversity in T lymphocytes present in blood, metastatic lesions, and DTH sites of two melanoma patients vaccinated with an IL-7 gene-modified autologous tumor cell vaccine.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 3, p. 243, doi. 10.1038/sj.cgt.7700435
- By:
- Publication type:
- Article
6
Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 3, p. 228, doi. 10.1038/sj.cgt.7700437
- By:
- Publication type:
- Article
7
Autocrine costimulation: Tumor-specific CD28-mediated costimulation of T cells by in situ production of a bifunctional B7–anti-CEA diabody fusion protein.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 3, p. 275, doi. 10.1038/sj.cgt.7700438
- By:
- Publication type:
- Article
8
In vivo induction of antitumor immunity and protection against tumor growth by injection of CD154-expressing tumor cells.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 3, p. 282, doi. 10.1038/sj.cgt.7700439
- By:
- Publication type:
- Article
9
Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 3, p. 236, doi. 10.1038/sj.cgt.7700440
- By:
- Publication type:
- Article
10
Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: Phase II randomized study comparing two dose levels.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 3, p. 289, doi. 10.1038/sj.cgt.7700441
- By:
- Publication type:
- Article
11
Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 3, p. 296, doi. 10.1038/sj.cgt.7700442
- By:
- Publication type:
- Article
12
Methotrexate selection of long-term culture initiating cells following transduction of CD34<sup>+</sup> cells with a retrovirus containing a mutated human dihydrofolate reductase gene.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 3, p. 308, doi. 10.1038/sj.cgt.7700443
- By:
- Publication type:
- Article